Categories: Health

HUTCHMED to Announce 2025 Half-Year Financial Results

 | Source: HUTCHMED (China) Limited

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 03, 2025 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:13) will announce its interim results for the six months ended June 30, 2025 on Thursday, August 7, 2025 at 7:00 am Eastern Daylight Time (EDT) / 12:00 noon British Summer Time (BST) / 7:00 pm Hong Kong Time (HKT).

HUTCHMED management will host two webcast presentations for analysts and investors to discuss the interim results, followed by Q&A sessions. The English webcast will be held on Thursday, August 7, 2025, at 8:00 am EDT (1:00 pm BST / 8:00 pm HKT). The Chinese (Putonghua) webcast will be held at 8:30 am HKT / 1:30 am BST on Friday, August 8, 2025 (8:30 pm EDT on Thursday, August 7, 2025).

Both webcasts will be available live via the company website at www.hutch-med.com/event/. The presentation will be available to download shortly before the webcast begins. A replay will also be available on the website shortly after the event.

About HUTCHMED

HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Since inception it has focused on bringing drug candidates from in-house discovery to patients around the world, with its first three medicines marketed in China, the first of which is also approved around the world including in the US, Europe and Japan. For more information, please visit: www.hutch-med.com or follow us on LinkedIn.

CONTACTS

Investor Enquiries +852 2121 8200 / ir@hutch-med.com
Media Enquiries
FTI Consulting – +44 20 3727 1030 / HUTCHMED@fticonsulting.com
Ben Atwell / Alex Shaw +44 7771 913 902 (Mobile) / +44 7779 545 055 (Mobile)
Brunswick – Zhou Yi +852 9783 6894 (Mobile) / HUTCHMED@brunswickgroup.com
Panmure Liberum Nominated Advisor and Joint Broker
Atholl Tweedie / Emma Earl / Rupert Dearden +44 20 7886 2500
Cavendish Joint Broker
Geoff Nash / Nigel Birks +44 20 7220 0500
Deutsche Numis Joint Broker
Freddie Barnfield / Jeffrey Wong / Duncan Monteith +44 20 7260 1000
GlobeNews Wire

Recent Posts

Manulife and UpLink Announce Winners of the ‘Innovating for Asia’s Demographic Future Challenge’

Challenge is second of three in a multiyear partnership to help shape the future of…

1 hour ago

Manulife Champions Longevity in Asia with Inaugural Symposium and Enhanced ManulifeMOVE

Over 1,000 attendees convened for the landmark event, graced by the presence of Minister of…

1 hour ago

Casio India brings its First-Ever Automatic watch to India with the Launch of EDIFICE EFK-100 series

~The legacy of Casio now transcends to the world of automatic timepieces, blending motorsport-inspired design…

4 hours ago

A New Era in Smart Living: ECOVACS Unveils DEEBOT X11 with PowerBoost Technology and Expands Service Robot Portfolio at IFA 2025

ECOVACS is introducing its groundbreaking robotic vacuum cleaner DEEBOT X11 at IFA 2025, taking innovation…

4 hours ago

ACKO Launches Support Initiative to Help Vehicle Owners Book HSRP Plates Before Maharashtra’s Extended Deadline

BENGALURU, India, Sept. 6, 2025 /PRNewswire/ -- The Maharashtra government has extended the deadline for installing…

4 hours ago

Yutong Bus Link+ Empowers Fleets with Intelligent Management and Higher Operational Efficiency

ZHENGZHOU, China, Sept. 5, 2025 /PRNewswire/ -- Yutong Bus ("Yutong", SHA: 600066), a leading global electric…

4 hours ago